retatrutide wikipedia Retatrutide: The New Triple-Agonist Weight Loss Treatment Retatrutide Molecular Structure and Properties

Clinically, the bar is the one described above

If youre suffering, check with your doctor If going on a GLP-1 suppresses your appetite to the point that youre not interested in eating at all, or if youre vomiting frequently or severely constipated, reach out to your provider: Your GLP-1 dosing may need to be lowered

Orforglipron is the worlds second oral GLP-1 pill for weight management, approved by the FDA in April 2026

CPG brands that ride this wave will be supported by GLP-1 brand ad spending thats predicted to soar from $1B in 2023 to an astounding $100B by 2030

Many trials have observed participants losing more weight than those on dual-agonist therapies, highlighting retatrutide as a new class of metabolic modulation

**For any medical procedures, patients may respond to treatment differently, each patients results may vary